Company / Cash per Share
Ligand Pharmaceuticals, Inc. Cash per Share History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Cash per Share
$9.16
FY2025
5-year range
$1.21 / $9.16
FY2021-FY2025
Trend
+122.3%
vs FY2024
Sector context
#21 of 205
Health Care
What the data says
Among 205 Health Care companies, Ligand Pharmaceuticals, Inc. is in the top 10% for cash per share. Cash per Share has fluctuated over the past 10 years, ranging from $0.94 in FY2016 to $9.16 in FY2025.
Based on SEC 10-K filings.
9.16 in FY2025 with a 5-year CAGR of +26.5%. Top quartile in the Health Care sector.
Improved from $1.35 to $9.16 over the past 2 years.
Health Care sector context is included.
Cash per Share over time
Growth rates
- 3-Year CAGR
- +50.5%
- 5-Year CAGR
- +26.5%
- 10-Year CAGR
- -
Sector benchmark
Top 10% in Health CareTop 10% of 205This company $9.16 Sector average $72.93
▼
-87.4% below sector average
Key checks
Key Insights
- In FY2025, cash per share increased 122.3% year-over-year.
- Ranks #21 out of 205 companies in the Health Care sector.
- Lowest cash per share in the period was in FY2016.
Company context
Key Data Points
- Low earnings quality (accrual-heavy earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Cash per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $9.16 | +122.3% |
| FY2024 | $4.12 | +204.2% |
| FY2023 | $1.35 | -49.6% |
| FY2022 | $2.68 | +121.1% |
| FY2021 | $1.21 | -57.1% |
| FY2020 | $2.83 | -17.8% |
| FY2019 | $3.45 | -37.8% |
| FY2018 | $5.54 | +461.8% |
| FY2017 | $0.99 | +4.9% |
| FY2016 | $0.94 | -81.1% |
As of FY2025 · SEC 10-K · Updated Feb 28, 2026